Tasly Pharmaceutical Group Co., Ltd.

Kaijing Yan

Xijun Yan

Naifeng Wu

Shunnan Zhang

He Sun

Xiaohui Ma

Yonghong Zhu

Ting Li

Xiaolin Bai

Yi He

Lei Li

Wensheng Zhang

Zhengliang Ye

Lihong Zhou

Hai'ou Dong

Lijun Fan

Yongfeng Zheng

Xiaobing Sun

Changsheng Rong

Liang Wang

Xuefei Cai

Hongbo Zhang

Zhixin Guo

Xiaofeng Liu

Weiwei Liu

Ruizhi Luo

Xiaofeng LiU

Chenming Li

Changwen Li

Guoguang Zhu

Cong Chen

Shiqing Wang

Libin Zhao

A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.

Pharmaceutical composition containing silybin and VE

Pharmaceutical composition containing silybin and ve

A traditional Chinese medicine composition for treating cardiovascular disease, and a preparation thereof, particularly a micro drop pill preparation thereof, and a method for preparing the preparation; the method for preparing the micro drop pill preparation can be used to prepare drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity.

Traditional Chinese medicine composition, and preparation and application thereof

The present invention relates to a preparation method for a traditional Chinese medicine drop pill and a traditional Chinese medicine micro drop pill prepared by using the method, and in particular, the present invention relates to a micro drop pill preparation method with high drug-loading capacity, simple preparation process and high production rate and a micro drop pill prepared by using the method. Specially, The drop pill preparation method used comprises the following steps: (1) material melting step: heat melting a medicine and a drop pill matrix to obtain a molten medicine liquid; (2) dropping step: delivering the molten medicine liquid to a dripper, and acquiring medicine drops of the molten medicine liquid by means of vibration dropping; and, (3) condensation step: cooling the medicine drops with a cooling gas to obtain micro drop pills.

Formulation of a micro drop pill and the preparation method thereof

An intelligent dripping pill machine for continuous liquid solidification comprises: a feeding device (), a material combining device (), a homogenizing device (), a dripping device () and a de-oiling device () sequentially connected via a transmission channel. The intelligent dripping pill machine removes, via high-speed centrifugation, a cooling liquid attached to dripping pills, and each component device is connected compactly, thereby achieving a continuous manufacturing operation, and reducing an occupied space of the devices as a whole while ensuring the yield of the dripping pills.

Intelligent dripping pill machine for continuous liquid solidification

An intelligent continuous manufacturing method via liquid cooling of dripping pills comprises the following steps: (1) feeding: weighing and transferring multiple materials respectively; (2) material combining: performing staged heating on the materials transferred in step (1), and mixing the same to obtain a material mixture, wherein an RSD of an effective ingredient in the material mixture &#x2264;5%; (3) homogenizing: pressurizing the material mixture obtained in step (2), and increasing the temperature, so as to obtain a homogenized material having the RSD of the effective ingredient in the material mixture &#x2264;5%; (4) dripping: performing vibration dripping on the homogenized material obtained in step (3) to obtain dripping pills, delivering the dripping pills into a cooling liquid to be cooled and then transferred; and (5) de-oiling: removing the cooling liquid on surfaces of the dripping pills obtained in step (4) via tilting centrifugation. The manufacturing method not only shortens the manufacturing process, but also ensures the dripping pill product to be more stable and homogeneous. In addition, high-speed centrifugation is used to reasonably de-oil the dripping pills to prevent contamination of the dripping pills and improve the circulation utilization rate of the cooling liquid.

Intelligent continuous manufacturing method via liquid cooling of dripping pills

Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.

Pharmaceutical composition containing silibinin

Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.

Pharmaceutical composition containing silibinin and pueraria root extract

A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.

Pharmaceutical composition containing silybin

A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.

Pharmaceutical composition containing silybin and L-carnitine

A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.

Pharmaceutical composition containing silybin, VE and L-carnitine

Traditional chinese medicine composition, and preparation and application thereof

Provided is the use of acomposition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of thecomposition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.

[object Object]

Growing community of inventors

Tianjin, China

Kaijing Yan